Amendola v. Bristol-Myers Squibb Co.

OPINION & ORDER

DENISE COTE, District Judge.

This litigation raises the question of whether pharmaceutical representatives (“PRs”) employed by a major pharmaceutical company are properly classified as exempt from the overtime compensation rules prescribed by the Fair Labor Standards Act, 29 U.S.C. § 201 et seq. (“FLSA”). Plaintiff Beth Amendola (“Am-endola”) has moved for discovery of the names and addresses of the defendant’s PRs, authorization for notice of this collective action to be sent to those potential plaintiffs, and equitable tolling of any claims they may file. Finding among other…